Confirmed Control Announced Deal verified Consumer HealthCPGDietary SupplementsNutraceuticalsVitaminsVitamins & Supplements

Atrium Innovations acquired by Nestlé

Nestlé agreed to acquire Atrium Innovations, a vitamins & supplements brand on Dec 5, 2017. The transaction value is shown as USD 2.3bn. The current comp implies EV / revenue of 3.3x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.

Transaction summary

Target
Atrium Innovations
Acquirer
Nestlé
Seller
-
Announced
2017-12-05
Geography
-
Tags
Consumer HealthCPGDietary SupplementsNutraceuticalsVitaminsVitamins & Supplements
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-06-19

Value and multiples

Price / value

$2.3B

Consideration | USD

Basis: Public source

EV / revenue

3.3x

unknown

Basis: FundComb estimate

EV / EBITDA

19x

Basis: FundComb estimate

Basis

  • USD 2.3bn consideration is treated as publicly disclosed or derived directly from public source data.
  • EV / revenue is shown as 3.3x based on the available comp inputs.
  • Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
  • EV / EBITDA is shown as 19x based on the available comp inputs.

Source summary

No public source summary has been published for this transaction yet.